Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19269 | 26666336 | BMC Gastroenterol | Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis. | 2015 | Details |
| A19270 | 26664666 | Ont Health Technol Assess Ser | Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis. | 2015 | Details |
| A19271 | 26663351 | Hepatology | Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice. | 2016 | Details |
| A19272 | 26663034 | Acta Physiol (Oxf) | Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress. | 2015 | Details |
| A19273 | 26663021 | Hepatology | Noninvasive fatty liver markers predict liver disease mortality in the U.S. population. | 2016 | Details |
| A19274 | 26663010 | Hepatobiliary Pancreat Dis Int | Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in mice. | 2015 | Details |
| A19275 | 26663004 | Hepatobiliary Pancreat Dis Int | Gut microbiota and non-alcoholic fatty liver disease. | 2015 | Details |
| A19276 | 26662852 | Hepatology | NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice. | 2016 | Details |
| A19277 | 26660688 | Obes Surg | Combined Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Sleeve Gastrectomy or Gastric Bypass?-a Controlled Matched Pair Study of 34 Patients. | 2016 | Details |
| A19278 | 26659452 | Hepatology | Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. | 2016 | Details |
| A19279 | 26657927 | Minerva Gastroenterol Dietol | Probiotics in digestive diseases: focus on Lactobacillus GG. | 2015 | Details |
| A19280 | 26657326 | Gastroenterology | Circadian Clock Control of Liver Metabolic Functions. | 2015 | Details |
| A19281 | 26656334 | Medicine (Baltimore) | Nonalcoholic Cirrhosis Increased Risk of Digestive Tract Malignancies: A Population-Based Cohort Study. | 2015 | Details |
| A19282 | 26655953 | J Biol Chem | Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice. | 2015 | Details |
| A19283 | 26654761 | Expert Rev Gastroenterol Hepatol | Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines. | 2015 | Details |
| A19285 | 26652175 | BMC Gastroenterol | Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study. | 2015 | Details |
| A19286 | 26651253 | Best Pract Res Clin Gastroenterol | Changing epidemiology of hepatocellular carcinoma in Asia. | 2015 | Details |
| A19287 | 26650570 | Endocrinology | Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice. | 2015 | Details |
| A19288 | 26648452 | J Cell Mol Med | miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21. | 2015 | Details |
| A19289 | 26648069 | Curr Drug Targets | Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib. | 2016 | Details |
| A19290 | 26646939 | Sci Data | Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes. | 2015 | Details |
| A19291 | 26646450 | Oncotarget | Activation of an endothelial Notch1-Jagged1 circuit induces VCAM1 expression, an effect amplified by interleukin-1β. | 2015 | Details |
| A19292 | 26645107 | J Cell Mol Med | Role of stem cells during diabetic liver injury. | 2015 | Details |
| A19293 | 26644818 | World J Hepatol | Vitamin E reduces liver stiffness in nonalcoholic fatty liver disease. | 2015 | Details |
| A19295 | 26642701 | Clin Lab | Therapeutic Effect of Metformin on Chemerin in Non-Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD). | 2015 | Details |
| A19296 | 26641143 | Expert Rev Gastroenterol Hepatol | The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target? | 2015 | Details |
| A19297 | 26640549 | Exp Ther Med | Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathway. | 2015 | Details |
| A19298 | 26640164 | Can J Physiol Pharmacol | Bicyclol attenuates tetracycline-induced fatty liver associated with inhibition of hepatic ER stress and apoptosis in mice. | 2015 | Details |
| A19299 | 26639394 | J Hepatol | Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. | 2015 | Details |
| A19302 | 26638195 | Hepatology | Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease. | 2016 | Details |
| A19304 | 26638128 | Hepatology | Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011). | 2016 | Details |
| A19305 | 26637970 | Hepatology | Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice. | 2016 | Details |
| A19306 | 26636520 | Eur Rev Med Pharmacol Sci | Is it possible a new definition of metabolic syndrome in childhood? | 2015 | Details |
| A19307 | 26636496 | Pharmacogenet Genomics | Phosphatidylethanolamine N-methyltransferase gene rs7946 polymorphism plays a role in risk of nonalcoholic fatty liver disease: evidence from meta-analysis. | 2016 | Details |
| A19308 | 26636408 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals. | 2016 | Details |
| A19309 | 26636404 | Eur J Gastroenterol Hepatol | Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men. | 2016 | Details |
| A19310 | 26635079 | BMC Gastroenterol | Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol. | 2015 | Details |
| A19311 | 26634964 | Free Radic Res | Liver ergothioneine accumulation in a guinea pig model of non-alcoholic fatty liver disease. A possible mechanism of defence? | 2015 | Details |
| A19312 | 26634892 | Phytother Res | Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway. | 2015 | Details |
| A19313 | 26634783 | Expert Rev Gastroenterol Hepatol | The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update. | 2015 | Details |
| A19314 | 26634687 | Clin Med (Lond) | An overview of the genetics, mechanisms and management of NAFLD and ALD. | 2015 | Details |
| A19315 | 26634485 | Genet Mol Res | Establishment of a hepatocyte steatosis model using Chang liver cells. | 2015 | Details |
| A19316 | 26633474 | Nutrients | The Emerging Role of Disturbed CoQ Metabolism in Nonalcoholic Fatty Liver Disease Development and Progression. | 2015 | Details |
| A19317 | 26632897 | Medicine (Baltimore) | Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19318 | 26632636 | Biomarkers | Candidate proteomic biomarkers for non-alcoholic fatty liver disease (steatosis and non-alcoholic steatohepatitis) discovered with mass-spectrometry: a systematic review. | 2015 | Details |
| A19319 | 26631018 | Lipids Health Dis | Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis. | 2015 | Details |
| A19320 | 26630411 | Int J Sport Nutr Exerc Metab | Waist-to-Hip Ratio is Related to Body Fat Content and Distribution Regardless of the Waist Circumference Measurement Protocol in Nonalcoholic Fatty Liver Disease Patients. | 2015 | Details |
| A19321 | 26630290 | PLoS One | Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion. | 2015 | Details |
| A19322 | 26629827 | PLoS One | Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate. | 2015 | Details |
| A19323 | 26629547 | EBioMedicine | Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals. | 2015 | Details |
| A19324 | 26629307 | J Radiol Case Rep | Minimally invasive percutaneous endovascular therapies in the management of complications of non-alcoholic fatty liver disease (NAFLD): A case report. | 2015 | Details |
| A19325 | 26629202 | Int J Clin Exp Med | Association of Adiponectin gene polymorphisms and nonalcoholic fatty liver disease. | 2015 | Details |
| A19326 | 26629094 | Int J Clin Exp Med | The effect of radish sourced 4-(Methylthio)-3-butenyl isothiocyanate on ameliorating the severity of high fat diet inducted nonalcoholic fatty liver disease in rats. | 2015 | Details |
| A19327 | 26628841 | J Clin Exp Hepatol | Animal Models Correlating Immune Cells for the Development of NAFLD/NASH. | 2015 | Details |
| A19328 | 26628836 | J Clin Exp Hepatol | Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice. | 2015 | Details |
| A19329 | 26627127 | Comp Biochem Physiol B Biochem Mol Biol | Expression of mitochondria-related genes is elevated in overfeeding-induced goose fatty liver. | 2015 | Details |
| A19330 | 26626909 | Dig Dis Sci | Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame. | 2015 | Details |
| A19331 | 26626650 | Ann Hepatol | Liver transplantation utilizing a severely fractured graft: every organ counts. | 2016 | Details |
| A19332 | 26626496 | J Hepatol | Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A19333 | 26626106 | J Natl Cancer Inst | Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care. | 2015 | Details |
| A19335 | 26623270 | J Clin Transl Hepatol | Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss. | 2015 | Details |
| A19336 | 26621917 | J Lipid Res | Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner. | 2015 | Details |
| A19337 | 26621860 | J Immunol | Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver. | 2015 | Details |
| A19338 | 26621325 | J Diabetes | Soluble epoxide hydrolase: A potential target for metabolic diseases. | 2016 | Details |
| A19339 | 26621219 | Sci Rep | Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis. | 2015 | Details |
| A19340 | 26620317 | Sci Rep | Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease. | 2015 | Details |
| A19341 | 26620139 | Semin Cardiothorac Vasc Anesth | Transfemoral Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease in Child's Class C Liver Disease Prior to Orthotopic Liver Transplantation: A Case Report. | 2015 | Details |
| A19342 | 26620035 | Mymensingh Med J | Non-alcoholic Fatty Liver Disease (NAFLD)--A Review. | 2015 | Details |
| A19343 | 26619823 | Sci Rep | Absence of Elovl6 attenuates steatohepatitis but promotes gallstone formation in a lithogenic diet-fed Ldlr(-/-) mouse model. | 2015 | Details |
| A19344 | 26619117 | J Clin Invest | E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis. | 2015 | Details |
| A19345 | 26618774 | PLoS One | A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study. | 2015 | Details |
| A19346 | 26617882 | Int J Clin Exp Pathol | Curcumin prevents the non-alcoholic fatty hepatitis via mitochondria protection and apoptosis reduction. | 2015 | Details |
| A19349 | 26615912 | Clin Nutr | Vitamin D deficiency in non-alcoholic fatty liver disease: The chicken or the egg? | 2015 | Details |
| A19350 | 26613528 | Horm Res Paediatr | Early Glucose Derangement Detected by Continuous Glucose Monitoring and Progression of Liver Fibrosis in Nonalcoholic Fatty Liver Disease: An Independent Predictive Factor? | 2015 | Details |
| A19351 | 26613006 | Diabetol Metab Syndr | The association of circulating levels of complement-C1q TNF-related protein 5 (CTRP5) with nonalcoholic fatty liver disease and type 2 diabetes: a case-control study. | 2015 | Details |
| A19352 | 26612838 | Toxicol Sci | Polychlorinated Biphenyl-Xenobiotic Nuclear Receptor Interactions Regulate Energy Metabolism, Behavior, and Inflammation in Non-alcoholic-Steatohepatitis. | 2015 | Details |
| A19353 | 26612588 | Biomark Med | Plasma IL-1 receptor antagonist levels correlate with the development of non-alcoholic steatohepatitis. | 2015 | Details |
| A19354 | 26610680 | Radiologe | [Functional MR imaging of the liver]. | 2015 | Details |
| A19355 | 26610348 | Gut Liver | Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan. | 2016 | Details |
| A19356 | 26609894 | Expert Opin Ther Targets | Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis. | 2016 | Details |
| A19357 | 26609343 | World J Hepatol | Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers. | 2015 | Details |
| A19358 | 26608915 | J Immunol | S100A8 Production in CXCR2-Expressing CD11b+Gr-1high Cells Aggravates Hepatitis in Mice Fed a High-Fat and High-Cholesterol Diet. | 2015 | Details |
| A19360 | 26608256 | Lancet | Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. | 2015 | Details |
| A19361 | 26606259 | Expert Rev Gastroenterol Hepatol | Circulating microRNAs in nonalcoholic fatty liver disease. | 2015 | Details |
| A19362 | 26605757 | Hepatology | The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage. | 2016 | Details |
| A19363 | 26603489 | Sci Rep | Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E. | 2015 | Details |
| A19364 | 26603137 | Am J Pathol | Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling. | 2015 | Details |
| A19365 | 26602919 | Int J Mol Sci | Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease? | 2015 | Details |
| A19366 | 26602577 | P R Health Sci J | A Comparison of Brunt's Criteria, the Non-Alcoholic Fatty Liver Disease Activity Score (NAS), and a Proposed NAS Scoring that Includes Fibrosis in Non-Alcoholic Fatty Liver Disease Staging. | 2015 | Details |
| A19370 | 26601667 | J Gastroenterol | The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease. | 2015 | Details |
| A19371 | 26601627 | Liver Int | The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment. | 2015 | Details |
| A19372 | 26600967 | World J Gastrointest Pathophysiol | Starring role of toll-like receptor-4 activation in the gut-liver axis. | 2015 | Details |
| A19373 | 26600855 | Res Pharm Sci | Effects of rosuvastatin and/or β-carotene on non-alcoholic fatty liver in rats. | 2015 | Details |
| A19374 | 26600310 | J Cell Biochem | Dietary Saturated Fat Promotes Development of Hepatic Inflammation Through Toll-Like Receptor 4 in Mice. | 2015 | Details |
| A19375 | 26600128 | PLoS One | Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice. | 2015 | Details |
| A19376 | 26600078 | Hepatology | The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. | 2016 | Details |
| A19377 | 26599819 | PLoS One | Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19378 | 26599575 | PLoS One | Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features. | 2015 | Details |
| A19379 | 26599361 | PLoS One | Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study. | 2015 | Details |
| A19380 | 26599351 | Hepatology | Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study. | 2016 | Details |